BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30909786)

  • 1. Patterns of Medical Cannabis Use among Cancer Patients from a Medical Cannabis Dispensary in New York State.
    Kim A; Kaufmann CN; Ko R; Li Z; Han BH
    J Palliat Med; 2019 Oct; 22(10):1196-1201. PubMed ID: 30909786
    [No Abstract]   [Full Text] [Related]  

  • 2. Patterns of Medical Cannabis Use Among Older Adults from a Cannabis Dispensary in New York State.
    Kaufmann CN; Kim A; Miyoshi M; Han BH
    Cannabis Cannabinoid Res; 2022 Apr; 7(2):224-230. PubMed ID: 33998868
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries.
    Tanco K; Olson A; Fellman B; Jankowski M; Lai SY; Shete S; Harbison K; Scheid J; Bruera E
    J Palliat Med; 2023 Nov; 26(11):1482-1487. PubMed ID: 37285183
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrahydrocannabinol and Cannabidiol Use in an Outpatient Palliative Medicine Population.
    Highet BH; Lesser ER; Johnson PW; Kaur JS
    Am J Hosp Palliat Care; 2020 Aug; 37(8):589-593. PubMed ID: 31986898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Cannabis Received by Patients According to Qualifying Condition in a US State Cannabis Program: Product Choice, Dosing, and Age-Related Trends.
    Lyu X; Illamola SM; Marino SE; Leppik IE; Dahmer S; Lehfeldt P; Conway JM; Remmel RP; Kingsley K; Birnbaum AK
    Curr Ther Res Clin Exp; 2023; 99():100709. PubMed ID: 37538850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing Efficacy and Use Patterns of Medical Cannabis for Symptom Management in Elderly Cancer Patients.
    Nathan R; Mupamombe CT; Elibol J; Case AA; Smith D; Hyland A; Attwood K; Hansen ED
    Am J Hosp Palliat Care; 2023 Apr; 40(4):368-373. PubMed ID: 35749740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis-based medicines--GW pharmaceuticals: high CBD, high THC, medicinal cannabis--GW pharmaceuticals, THC:CBD.
    Drugs R D; 2003; 4(5):306-9. PubMed ID: 12952500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potency and Therapeutic THC and CBD Ratios: U.S. Cannabis Markets Overshoot.
    Pennypacker SD; Cunnane K; Cash MC; Romero-Sandoval EA
    Front Pharmacol; 2022; 13():921493. PubMed ID: 35734402
    [No Abstract]   [Full Text] [Related]  

  • 9. Concerns of Patients With Cancer on Accessing Cannabis Products in a State With Restrictive Medical Marijuana Laws: A Survey Study.
    Singh V; Zarrabi AJ; Curseen KA; Sniecinski R; Welsh JW; McKenzie-Brown AM; Baer W; Gillespie TW
    J Oncol Pract; 2019 Oct; 15(10):531-538. PubMed ID: 31442099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey.
    Corroon J; Sexton M; Bradley R
    BMC Fam Pract; 2019 Dec; 20(1):174. PubMed ID: 31837706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Authorization Patterns, Safety, and Effectiveness of Medical Cannabis in Quebec.
    Kalaba M; MacNair L; Peters EN; Eglit GML; Rapin L; Hage CE; Prosk E; Ware MA
    Cannabis Cannabinoid Res; 2021 Dec; 6(6):564-572. PubMed ID: 33998902
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil.
    Morini L; Porro G; Liso M; Groppi A
    Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Observational Cross-Sectional Survey Exploring the Indications for and Responses to Medical Marijuana Use in Certified Patients in Pennsylvania.
    Kimless D; Caloura M; Markos V; Ryan J; Abbonizio S; Janicki S
    J Prim Care Community Health; 2022; 13():21501319221129734. PubMed ID: 36226444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of Cannabis Use to Patient-Reported Symptoms in Cancer Patients Seeking Supportive/Palliative Care.
    Donovan KA; Chang YD; Oberoi-Jassal R; Rajasekhara S; Smith J; Haas M; Portman DG
    J Palliat Med; 2019 Oct; 22(10):1191-1195. PubMed ID: 30794025
    [No Abstract]   [Full Text] [Related]  

  • 15. Use and caregiver-reported efficacy of medical cannabis in children and adolescents in Switzerland.
    Zürcher K; Dupont C; Weber P; Grunt S; Wilhelm I; Eigenmann DE; Reichmuth ML; Fankhauser M; Egger M; Fenner L
    Eur J Pediatr; 2022 Jan; 181(1):335-347. PubMed ID: 34309706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A selective review of medical cannabis in cancer pain management.
    Blake A; Wan BA; Malek L; DeAngelis C; Diaz P; Lao N; Chow E; O'Hearn S
    Ann Palliat Med; 2017 Dec; 6(Suppl 2):S215-S222. PubMed ID: 28866904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
    Krcevski-Skvarc N; Wells C; Häuser W
    Eur J Pain; 2018 Mar; 22(3):440-454. PubMed ID: 29134767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marijuana use among patients with epilepsy at a tertiary care center.
    Kerr A; Walston V; Wong VSS; Kellogg M; Ernst L
    Epilepsy Behav; 2019 Aug; 97():144-148. PubMed ID: 31252269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Association between Cannabis Product Characteristics and Symptom Relief.
    Stith SS; Vigil JM; Brockelman F; Keeling K; Hall B
    Sci Rep; 2019 Feb; 9(1):2712. PubMed ID: 30804402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.